CTLA-4 and its ligands on the surface of T- and B-lymphocyte subsets in chronic hepatitis B virus infection

Journal of the Medical Association of Thailand

Volumn 96, Issue SUPPL.1, 2013, Pages

  Wongjitrat, Chatchawan ^a   Sukwit, Suchitra ^b   Chuenchitra, Thippawan ^b   Seangjaruk, Patcharin ^a   Rojanasang, Pornparn ^a   Romputtan, Pornsuk ^a   Srisurapanon, Surangrat ^a  

^a SRINAKHARINWIROT UNIVERSITY   (Thailand)

^b ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

Author keywords

Chronic hepatitis B virus; Co stimulatory molecules; CTLA 4; Flow cytometer; Immune regulation; Ligands; Lymphocyte subsets

Indexed keywords

B7 ANTIGEN; CD19 ANTIBODY; CD3 ANTIBODY; CD4 ANTIBODY; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; MONOCLONAL ANTIBODY; OKT 8; PROGRAMMED DEATH 1 LIGAND 1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE SUBPOPULATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, CD274; B-LYMPHOCYTE SUBSETS; CASE-CONTROL STUDIES; CTLA-4 ANTIGEN; FEMALE; FLOW CYTOMETRY; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTE SUBSETS;

EID: 84876849378     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Liu CJ, Chen DS, Chen PJ. Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. J Clin Virol 2006; 36 (Suppl 1): S33-44.
2. Dandri M, Locarnini S. New insight in the pathobiology of hepatitis B virus infection. Gut 2012; 61 (Suppl 1): i6-17.
3. Bertoletti A, Ferrari C. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 2011. Gut doi:10.1136/gutjnl-2011-301073.
4. Desmond CP, Gaudieri S, James IR, Pfafferott K, Chopra A, Lau GK, et al. Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease. J Virol 2012; 86: 1181-92.
5. Nebbia G, Peppa D, Maini MK. Hepatitis B infection: current concepts and future challenges. QJM 2012; 105: 109-113.
6. Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol 2002; 2: 116-26.
7. Alegre ML, Frauwirth KA, Thompson CB. T-cell regulation by CD28 and CTLA- 4. Nat Rev Immunol 2001; 1: 220-228.
8. Bretscher PA. A two-step, two-signal model for the primary activation of precursor helper T cells. Proc Natl Acad Sci USA 1999; 96: 185-90.
9. Mueller DL. T cells: A proliferation of costimulatory molecules. Curr Biol 2000; 10: R227-30.
10. Han Q, Duan S, Zhang G, Li Z, Li N, Zhu Q, et al. Associations between cytotoxic T lymphocyteassociated antigen-4 polymorphisms and serumtumor necrosis factor-alpha and interferon-gamma levels in patients with chronic hepatitis B virus infection. Inflamm Res 2011; 60: 1071-8.
11. Schurich A, Khanna P, Lopes AR, Han KJ, Peppa D, Micco L, et al. Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis- Prone CD8 T cells in persistent hepatitis B virus infection. Hepatology 2011; 53: 1494-503.
12. Maier H, Isogawa M, Freeman GJ, Chisari FV. PD- 1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver. J Immunol 2007; 178: 2714-2720.
13. Zhang G, Han Q, Duan S, Li Z, Li N, Zhu Q, et al. PDCD1 polymorphism amplifies the predisposing effect conferred by CTLA4 polymorphism in chronic hepatitis B virus infection. Hum Immunol 2012; 73: 421-5.
14. Milich DR, Chen M, Schodel F, Peterson DL, Jones JE, Hughes JL. Role of B cells in antigen presentation of the hepatitis B core. Proc Natl Acad Sci USA 1997; 94: 14648-53.
15. Fields PE, Finch RJ, Gray GS, Zollner R, Thomas JL, Sturmhoefel K, et al. B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells. J Immunol 1998; 161: 5268-75.
16. Salek-Ardakani S, Arens R, Flynn R, Sette A, Schoenberger SP, Croft M. Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells. J Immunol 2009; 182: 2909-18.
17. Bertoletti A, Gehring AJ. The immune response during hepatitis B virus infection. J Gen Virol 2006; 87: 1439-49.
18. Maini MK, Schurich A. The molecular basis of the failed immune response in chronic HBV: therapeutic implications. J Hepatol 2010; 52: 616-9.
19. Chen L, Zhang Z, Chen W, Zhang Z, Li Y, Shi M, et al. B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B. J Immunol 2007; 178: 6634-41.
20. Probst HC, McCoy K, Okazaki T, Honjo T, van den BM. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA- 4. Nat Immunol 2005; 6: 280-6.
21. Read S, Greenwald R, Izcue A, Robinson N, Mandelbrot D, Francisco L, et al. Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo. J Immunol 2006; 177: 4376-83.
22. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 2001; 193: 1303-10.
23. Baecher-Allan C, Viglietta V, Hafler DA. Human CD4+CD25+ regulatory T cells. Semin Immunol 2004; 16: 89-98.
24. Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, Kusters JG, et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005; 41: 771-8.
25. Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z, et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006; 177: 739-47.
26. Nakamoto N, Cho H, Shaked A, Olthoff K, Valiga ME, Kaminski M, et al. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog 2009; 5: e1000313.
27. Das A, Hoare M, Davies N, Lopes AR, Dunn C, Kennedy PT, et al. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med 2008; 205: 2111-24.